Oct. 20 at 4:46 PM
$ALT Thanks again to @Wolly99 for his regular posting of misinformation. I feel compelled to research what you post because it usually leads to buying opportunities in
$ALT competitors. Did you know that there's more than one AI Fibrosis Reader out there making waves? Look at HistoIndex. Looks like it's already used by
$AKRO and
$SGMT. Gave me a chance to look at SGMT also, and it looks like another "competitor" of
$ALT's that has better results.
For those pumping
$ALT, I hope you realize it's a useless battle.
$ALT is behind significant in the MASH/Fibrosis/Obesity races.
$ALT is a "Has been", at best. Intriguing argument for what many THOUGHT Prmvi "could" do, only to be squashed when data showed what it CAN'T do.
Bag holders unite!
https://www.prnewswire.com/news-releases/histoindex-to-debut-fibrosight-plus-and-showcase-latest-scientific-findings-at-aasld-the-liver-meeting-2025-302584158.html
